Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferasirox Palatability and Tolerability Study
NCT00845871Phase 4Completed
- Sponsor
- Novartis
- Start
- May 2009
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of deferasirox in transfusion hemosiderosis, sponsored by Novartis. Primary endpoint: Percentage of Participants With Differing Palatability Scores at Week 12. Started May 2009; status: completed.
02
Drugs
deferasirox
03
Conditions
transfusion hemosiderosis
Beyond the preview
Go deeper on NCT00845871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00845871.